Viking Therapeutics
VKTX
#2409
Rank
NZ$10.46 B
Marketcap
$93.94
Share price
-9.14%
Change (1 day)
456.56%
Change (1 year)

Viking Therapeutics (VKTX) - Cash on Hand

Cash on Hand as of September 2024 : NZ$1.58 Billion

According to Viking Therapeutics 's latest financial reports the company has NZ$1.58 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Viking Therapeutics - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.57 B133.79%
2022-12-31NZ$0.24 B-17.23%
2021-12-31NZ$0.29 B-14.05%
2020-12-31NZ$0.34 B-15.89%
2019-12-31NZ$0.40 B-8.95%
2018-12-31NZ$0.44 B1451.61%
2017-12-31NZ$28.97 M52.6%
2016-12-31NZ$18.98 M-7.87%
2015-12-31NZ$20.6 M2036.15%
2014-12-31NZ$0.96 M341.35%
2013-12-31NZ$0.21 M
2012-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$1.30 B-17.91%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.38 B-13.04%๐Ÿ‡บ๐Ÿ‡ธ USA